David J. Dykeman, co-chair of the
Life Sciences & Medical Technology Practice of global law firm
Greenberg Traurig, LLP and co-managing shareholder of the firm's
Boston office, and Roman Fayerberg, co-chair of the Boston office's Intellectual Property (IP)
& Technology Practice, will present on the DeviceTalks Boston
panel, "How IP Can Drive Funding & Exits," May 1, from 11:30 a.m. -
12:15 p.m. EDT.
BOSTON, April 26,
2024 /PRNewswire/ -- David J.
Dykeman, co-chair of the Life Sciences & Medical
Technology Practice of global law firm Greenberg Traurig, LLP and
co-managing shareholder of the firm's Boston office, and Roman Fayerberg, co-chair of the Boston office's Intellectual Property (IP)
& Technology Practice, will present on the DeviceTalks Boston
panel, "How IP Can Drive Funding & Exits," May 1, from 11:30 a.m. -
12:15 p.m. EDT.
The panel will focus on how IP is key for medical technology
companies to attract funding and navigate exits. The panelists will
provide insights into best practices and pitfalls to avoid when
creating a strategic and competitive patent portfolio to close
funding and secure exits.
A registered patent attorney with over 25 years of experience in
patent and IP law, Dykeman focuses his practice on securing
worldwide IP protection and related business strategy for high-tech
clients, with particular experience in life sciences, medical
devices, robotics, materials, and information technology. He
provides strategic patent portfolio development and intellectual
property advice for clients including major research institutions,
multinational corporations, and startup companies. He serves on the
board of directors of MassMEDIC and was named "Massachusetts Patent
Strategy Attorney of the Year" by LMG Life Sciences in 2022.
Fayerberg is a registered patent attorney with broad experience
helping clients strategically protect and leverage their
innovations globally. He works with clients to develop and manage
worldwide patent portfolios and counsels clients regarding freedom
to operate, patent landscape, and patent infringement and validity
matters. Fayerberg also conducts and defends patent due diligence
investigations in connection with venture capital investments,
mergers and acquisitions, and licensing opportunities. He has
represented clients ranging from startups to global companies in a
variety of technical areas, including medical devices, robotics,
diagnostic and imaging systems, microfluidic devices, and
biotechnology.
About Greenberg Traurig's Life Sciences & Medical Technology
Group: Greenberg Traurig's Life Sciences & Medical Technology
Group advises clients ranging from startups to large multinational
public companies to leading research institutions. The group's
attorneys work closely with clients, providing innovative legal
counsel to help them achieve their objectives – from discovery
through commercialization and product marketing.
About Greenberg Traurig's Boston Office: Celebrating 25 years of
legal excellence, Greenberg Traurig's Boston office is home to more than 90
attorneys practicing in the areas of banking and finance,
corporate, emerging technology, energy, environmental, gaming,
governmental affairs, intellectual property, labor and employment,
life sciences and medical technology, litigation, public finance,
real estate, restructuring and bankruptcy, tax, and white collar
defense and investigations. An important contributor to the firm's
international platform, the Boston
office includes a team of nationally recognized attorneys with both
public and private sector experience. Working collaboratively with
the firm's global network, the Boston team collectively offers clients
decades of experience advising on complex legal matters and
providing hands-on knowledge of the local business community.
About Greenberg Traurig: Greenberg Traurig, LLP has more than
2750 attorneys in 47 locations in the
United States, Europe and
the Middle East, Latin America, and Asia. The firm is a 2022 BTI "Highly
Recommended Law Firm" for superior client service and is
consistently among the top firms on the Am Law Global 100 and NLJ
500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The
Diversity Lab. The firm is recognized for powering its U.S. offices
with 100% renewable energy as certified by the Center for Resource
Solutions Green-e® Energy program and is a member of the U.S. EPA's
Green Power Partnership Program. The firm is known for its
philanthropic giving, innovation, diversity, and pro bono. Web:
http://www.gtlaw.com.
Media Contact
Jessica Feldman, Greenberg
Traurig, LLP, 617.310.5273, Jessica.Feldman@gtlaw.com,
www.gtlaw.com/en
Twitter
View original
content:https://www.prweb.com/releases/greenberg-traurigs-david-dykeman-and-roman-fayerberg-to-present-at-devicetalks-boston-302129059.html
SOURCE Greenberg Traurig, LLP